Description

Pharmacokinetics and Pharmacodynamics:

Adefovir dipivoxil belongs to the class of nucleotide analog reverse transcriptase inhibitors (NRTIs). It works by inhibiting the reverse transcriptase enzyme, crucial for the replication of HBV DNA. By interfering with viral replication, adefovir dipivoxil helps reduce HBV viral load and slow disease progression. Pharmacokinetic studies have shown that after oral administration, adefovir dipivoxil is well-absorbed, reaching peak plasma concentrations within 1 to 2 hours.

Formulations:

Our Adefovir Dipivoxil Range is available in tablet form, with each tablet containing 10 mg of adefovir dipivoxil. Each pack contains 30 tablets, providing a convenient and comprehensive treatment regimen.

Indications:

Our Adefovir Dipivoxil Range is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults.

Usage:

For optimal results, it is essential to follow your healthcare provider’s instructions carefully. Take the prescribed dose of Adefovir Dipivoxil Range orally, with or without food, as directed by your physician.

Dosage:

The recommended dosage of Adefovir Dipivoxil Range is 10 mg once daily. Your healthcare provider may adjust the dosage based on your individual response to treatment and the severity of your condition.

Side Effects:

While Adefovir Dipivoxil Range is generally well-tolerated, some individuals may experience side effects. Common side effects may include nausea, vomiting, diarrhea, headache, or fatigue. If you experience any severe or persistent side effects, contact your healthcare provider immediately.

Conclusion:

At AIT Pharmaceuticals Division, we are committed to developing innovative solutions to improve patient outcomes. Our Adefovir Dipivoxil Range represents our dedication to excellence in pharmaceutical research and development. Trust AIT Pharmaceuticals Division for your healthcare needs and experience the difference in quality and efficacy.